Among the eight people Robert F. Kennedy Jr. announced would make up his new group of outside vaccine advisers to the US ...

The safety of approved mRNA vaccines is well-established and, as with other vaccines, continues to be monitored by multiple ...

Moderna (MRNA) ended the recent trading session at $26.68, demonstrating a -2.45% change from the preceding day's closing price. The stock's change was less than the S&P 500's daily loss of 1.13%. At ...

Amidst an ongoing outbreak of a deadly bird flu virus in livestock, the US Department of Agriculture is doing more to prevent ...

Robert Malone, who believes the U.S. government has “reality-bending information-control capabilities,” will guide the future ...

Several states have effectively declared war on medical progress. Lawmakers in Iowa, Idaho, Texas, and Kentucky have introduced bills that would ban or restrict vaccines that use messenger RNA, or ...

The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include individuals 18-59 years of age who are at increased risk for severe illness from ...

The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the disease.

Kennedy Jr.’s unprecedented firing on June 9 of all 17 members of the Advisory Committee on Immunization Practices (ACIP) of ...

It plays a big role in deciding which vaccines kids and adults get routinely, what’s covered by insurance and which shots are ...

The negative sentiment towards the S&P 500 Health Care Index Sector (XLV) softened in May as average short interest dipped to ...